BILL to Participate in Upcoming Investor Conferences
Get Alerts BILL Hot Sheet
Join SI Premium – FREE
SAN JOSE, Calif.--(BUSINESS WIRE)-- BILL (NYSE: BILL), a leading financial operations platform for small and midsize businesses (SMBs), today announced its participation in the following upcoming investor conferences:
Citi FinTech Conference |
|
Tuesday, February 27, 2024 at 5:45 a.m. PT |
|
Morgan Stanley Technology, Media & Telecom Conference |
|
Tuesday, March 5, 2024 at 11:00 a.m. PT |
|
KeyBanc Emerging Technology Summit |
|
Wednesday, March 6, 2024 at 1:00 p.m. PT |
|
Wolfe FinTech Forum |
|
Wednesday, March 13, 2024 at 11:25 a.m. PT |
Live webcasts, as well as replays, will be available on the Company's investor relations website at https://investor.bill.com/. Please note presentation times are subject to change.
About BILL:
BILL (NYSE: BILL) is a leading financial operations platform for small and midsize businesses (SMBs). As a champion of SMBs, we are automating the future of finance so businesses can thrive. Our integrated platform helps businesses to more efficiently control their payables, receivables and spend and expense management. Hundreds of thousands of businesses rely on BILL’s proprietary member network of millions to pay or get paid faster. Headquartered in San Jose, California, BILL is a trusted partner of leading U.S. financial institutions, accounting firms, and accounting software providers. For more information, visit bill.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223198860/en/
IR Contact:
Karen Sansot
[email protected]
Press Contact:
John Welton
[email protected]
Source: BILL
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
- FERRERO GROUP TO ACQUIRE PURELY ELIZABETH, A LEADING U.S. MODERN WELLNESS BRAND
- Nanochon Receives Regulatory Approval from Panamá's Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Citi, KeyBanc, Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share